Information for children and young people

Guidance and advice

For parents

COVID-19 Vaccination programme for children and young people – guidance for parents
18 November 2021

COVID-19 vaccination: checklist for parents of children aged 12 to 15 years (gov.uk)
17 November 2021

For schools, colleges and universities

Immunisation Programme delivery during an outbreak in the school

COVID-19: provision of immunisation sessions for outbreaks in schools (gov.uk)
22 September 2021

A MMR, MenACWY and COVID-19 vaccines communications toolkit for universities is available to download.

British Sign Language (BSL)

British Sign Language (BSL) videos are also available at COVID-19 vaccination: British Sign Language resources (gov.uk)

Authorised vaccines and patient information leaflet (PIL)

Vaccine Product Information

This information is a copy of the product information for COVID-19 vaccines, which outlines the conditions under which the vaccine should be used and information on its known safety.

This information may be updated, if necessary.

The MHRA is unable to offer medical advice and so if a patient has any questions about a vaccine they should contact their doctor or pharmacist. Suspected adverse reactions to a vaccine can be Yellow Card.

The Information for UK and IOM recipients document provides information for patients.

Pfizer/BioNTech vaccine

Information about the Pfizer/BioNTech COVID-19 vaccine, approved for supply by MHRA on 2 December 2020.

Information for UK and IOM recipients on Pfizer/BioNTech COVID-19 vaccine.

Further details about the regulatory approval of Pfizer / BioNTech vaccine for COVID-19.

AstraZeneca vaccine

Information about the AstraZeneca vaccine, approved for supply by MHRA on 30 December 2020.

Information for UK and IOM recipients on COVID 19 Vaccine AstraZeneca.

Further details about the regulatory approval of COVID-19 Vaccine AstraZeneca.

Spikevax vaccine

Spikevax dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) [formerly COVID-19 Vaccine Moderna].

Information about the Spikevax vaccine, approved for supply by MHRA on 8 January 2021.

Information for UK and IOM recipients on COVID-19 Vaccine Spikevax.

Further details about the regulatory approval of COVID-19 Vaccine Spikevax.

Side Effects

Blood clotting, myocarditis and pericarditis, and Guillain-Barré Syndrome (GBS).

See COVID-19 vaccination and rare side effects (gov.uk) for information and guidance on these very rare conditions reported after COVID-19 vaccination.

Online appointment booking system

If you are housebound and unable to travel, please do not use the online registration tool. Please call COVID 111 to arrange an appointment instead.

Consent Form for children, young people and at risk groups aged 12-17 years

Cominarty® Children and Young People 12-17 years at risk [PDF]
24 November 2021

Best Interest, Residential, Relative and Clinician Opinion forms are also available on request.

Vaccination Cards are supplied with each dose of vaccine.

These will be given to the recipient with information about their vaccine: the date given and the date of appointment for their second or future doses.

Digital vaccine record

Download your vaccination status via the NHS App
Mobile Phone App: UK NHS COVID Pass for use by Isle of Man residents.

As the COVID-19 programme continues to change please check items regularly for any updates or changes.

Public Health Isle of Man has adapted the information supplied by JCVI and PHE for the delivery of the COVID-19 Vaccination programme and this has been sourced from COVID-19 vaccination programme (gov.uk)

Updated 23 November 2021